Sugar: a shove to industry rather than a nudge to consumers?
Lobstein T The Lancet Diabetes & Endocrinology. Pub. Online: 06 January 2016 http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00483-0/abstract
Leggi
Gradual reduction of sugar in soft drinks without substitution as a strategy to reduce overweight, obesity, and type 2 diabetes: a modelling study
Ma Y, He FJ, Yin Y, et al. The Lancet Diabetes & Endocrinology.Pub. Online: 06 January 2016 http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00477-5/abstract
Leggi
Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study
Colchero MA, Popkin BM, Rivera JA, Wen Ng S BMJ.Pub. 06 January 2016 http://www.bmj.com/content/352/bmj.h6704?utm_source=marketing_email&utm _medium=email&utm_campaign=WNOL_070116&utm_content=Research&utm_term=
Leggi
Low Calorie Beverage Consumption Is Associated with Energy and Nutrient Intakes and Diet Quality in British Adults
Gibson SA, Horgan GW, Francis LE Nutrients 2016;8(1):9 http://www.mdpi.com/2072-6643/8/1/9
Leggi
Glycemic index, glycemic load, and common psychological disorders
Haghighatdoost F, Azadbakht L, Keshteli AH, et al. Am J Clin Nutr 2016;103:201-9 http://ajcn.nutrition.org/content/103/1/201.abstract
Leggi
Sex differences in body anthropometry and composition in individuals with and without diabetes in the UK Biobank
Peters SAE, Huxley RR, Woodward M BMJ.Open 2016;6:e010007 http://bmjopen.bmj.com/content/6/1/e010007.abstract
Leggi
The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
Blomster JI, Woodward M, Zoungas S, et al. BMJ.Open 2016;6:e009668 http://bmjopen.bmj.com/content/6/1/e009668.abstract
Leggi
Patient-centred care, health behaviours and cardiovascular risk factor levels in people with recently diagnosed type 2 diabetes: 5-year follow-up of the ADDITION-Plus trial cohort
Dambha-Miller H, Cooper AJM, Simmons RK, et al. BMJ.Open 2016;6:e008931 http://bmjopen.bmj.com/content/6/1/e008931.abstract
Leggi
Metformin as firstline treatment for type 2 diabetes: are we sure?
Boussageon R, Gueyffier R and Cornu C BMJ 2016;352 http://www.bmj.com/content/352/bmj.h6748
Leggi
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Forslund K, Hildebrand F, Nielsen T, et al. Nature. 2015 Dec 2. In press http://www.ncbi.nlm.nih.gov/pubmed/26618873
Leggi